GALAPAGOS
GALAPAGOS NV, commonly referred to as Galapagos, is a pioneering biotechnology company headquartered in the United States, with significant operations in Europe. Founded in 1999, Galapagos has established itself in the pharmaceutical industry, focusing on the discovery and development of innovative medicines for various diseases, including inflammatory and fibrotic conditions. The company is renowned for its unique drug discovery platform, which leverages advanced technologies to identify and develop novel therapeutic candidates. Notable achievements include the successful development of several clinical-stage programmes, positioning Galapagos as a leader in the biopharmaceutical sector. With a commitment to scientific excellence and a robust pipeline, Galapagos continues to make significant strides in transforming patient care through groundbreaking therapies.
DitchCarbon Score
How does GALAPAGOS's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Education Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
GALAPAGOS's score of 42 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.
GALAPAGOS's reported carbon emissions
In 2023, GALAPAGOS reported total carbon emissions of approximately 36,537,000 kg CO2e across all scopes. This includes 2,922,000 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 1,132,000 kg CO2e from Scope 2 emissions, which are indirect emissions from the generation of purchased electricity, steam, heating, and cooling. The majority of their emissions, about 32,483,000 kg CO2e, stem from Scope 3, which encompasses all other indirect emissions in the value chain. In comparison, in 2022, GALAPAGOS emitted approximately 54,609,000 kg CO2e, indicating a significant reduction in total emissions. The breakdown for 2022 included 3,180,000 kg CO2e from Scope 1, 849,000 kg CO2e from Scope 2, and 54,609,000 kg CO2e from Scope 3 emissions. Despite these reductions, GALAPAGOS has not publicly committed to specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or climate pledges. The company continues to monitor and report its emissions, aligning with industry standards for transparency and accountability in climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 3,180,000 | 0,000,000 |
| Scope 2 | 217,000 | 000,000 |
| Scope 3 | 54,609,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
GALAPAGOS is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
